Senior insider sale
SVP, Chief Financial Officer at SANA BIOTECHNOLOGY, INC. — senior position signals high conviction
$180.8K
45.80K shares
What this filing means
HARDY NATHAN plans to sell 45.80K shares of SANA BIOTECHNOLOGY, INC. valued at approximately $180.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/21/2024ACC: 0001950047-24-007830
Officer· SVP, Chief Financial Officer
Since Feb 2021
45.80K
Shares to sell
$180.8K
Approx. market value
45.80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/21/2024
45.80KTotal acquired45.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/21/2024 | Stock Option Exercise Cash | 45.80K | — |
| Total | 45.80K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
45.80K
Market value
$180.8K
10/21/2024
Total
Units
45.80K
Value
$180.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/21/2024 | 45.80K | $180.8K | NASDAQ | Planned |
| Total | 45.80K | $180.8K | ||